154 related articles for article (PubMed ID: 4557857)
1. Antitumor and mutagenic properties of a variety of heterocyclic nitrogen and sulfur mustards.
Creech HJ; Preston RK; Peck RM; O'Connell AP
J Med Chem; 1972 Jul; 15(7):739-46. PubMed ID: 4557857
[No Abstract] [Full Text] [Related]
2. Synthesis and anticancer activity of 5-diethylaminomethyl derivatives and nitrogen mustards of uracil and 2-thiouracils.
Fabrissin S; de Nardo M; Nisi C; Morasca L; Dolfini E; Franchi G
J Med Chem; 1976 May; 19(5):639-42. PubMed ID: 1271405
[TBL] [Abstract][Full Text] [Related]
3. N-(2-chloroethyl)-N-(2-hydroxyethyl)arylamines. Possible intermediates to potential carcinolytic agents bearing dissimilar reactive functions.
Foster AB; Jarman M; Ross WC; Tisdale MJ
J Med Chem; 1972 Aug; 15(8):869-70. PubMed ID: 5044312
[No Abstract] [Full Text] [Related]
4. Mixed bifunctionality. II. Relation of antitumor activity to structure in alkylating agents derived from polynuclear aromatic hydrocarbons.
Peck RM; O'Connell AP; Creech HJ
J Med Chem; 1970 Mar; 13(2):284-8. PubMed ID: 5418503
[No Abstract] [Full Text] [Related]
5. Antitumor and antileukemic effects of some steroids and other biologically interesting compounds containing an alkylating agent.
Carroll FI; Philip A; Blackwell JT; Taylor DJ; Wall ME
J Med Chem; 1972 Nov; 15(11):1158-61. PubMed ID: 4654665
[No Abstract] [Full Text] [Related]
6. [Research on compounds with antiblastic activity. XLI. Synthesis of new nitrogen mustards correlated with N,N-bis-(beta-chlorethyl) aniline].
Artico M; Filacchioni G; Vomero S
Farmaco Sci; 1971 Sep; 26(9):805-11. PubMed ID: 5157547
[No Abstract] [Full Text] [Related]
7. [Correlations between the chemical structure of Mannich bases with and without nitrogen mustard groups and their cytostatic effect on Ehrlich ascites carcinoma in albino mice].
Werner W; Jungstand W; Gutsche W
Arzneimittelforschung; 1970 Feb; 20(2):246-9. PubMed ID: 5467470
[No Abstract] [Full Text] [Related]
8. Comparative antitumor effects of peptichemio and other alkylating agents.
Schmid FA; Banks SE; Stock CC
Cancer Treat Rep; 1977; 61(3):473-5. PubMed ID: 872145
[No Abstract] [Full Text] [Related]
9. Isoquinolines. 6. Potential central nervous system antitumor agents. Nitrogen mustards of 3-amino-4-(p-aminophenyl)isoquinoline.
Filer CN; Granchelli FE; Soloway AH; Neumeyer JL
J Med Chem; 1977 Nov; 20(11):1504-8. PubMed ID: 915914
[TBL] [Abstract][Full Text] [Related]
10. Potential antitumor agents: steroidal amidoesters with an alkylating moiety.
Papageorgiou A; Boutis L; Nicolaropoulos S; Catsoulacos P
Oncology; 1987; 44(2):128-32. PubMed ID: 3574853
[TBL] [Abstract][Full Text] [Related]
11. Isolation, synthesis, and antitumor evaluation of spirohydantoin aziridine, a mutagenic metabolite of spirohydantoin mustard.
Struck RF; Kirk MC; Rice LS; Suling WJ
J Med Chem; 1986 Jul; 29(7):1319-21. PubMed ID: 3543361
[TBL] [Abstract][Full Text] [Related]
12. Cytostatic effect of homo-aza-steroidal esters in vivo and in vitro. Structure-activity relationships.
Catsoulacos P; Camoutsis C; Papageorgiou A; Adamiak-Margariti E
Anticancer Res; 1992; 12(5):1617-20. PubMed ID: 1444229
[TBL] [Abstract][Full Text] [Related]
13. Relationships between structure, toxicity and genetic effects in Salmonella typhimurium and Saccharomyces cerevisiae for substituted aniline mustards.
Ferguson LR; Palmer BD; Denny WA
Mutat Res; 1989 Sep; 224(1):95-104. PubMed ID: 2671716
[TBL] [Abstract][Full Text] [Related]
14. Frameshift mutagenesis in Salmonella.
Ames BN; Whitfield HJ
Cold Spring Harb Symp Quant Biol; 1966; 31():221-5. PubMed ID: 4866378
[No Abstract] [Full Text] [Related]
15. DNA-directed alkylating agents. 1. Structure-activity relationships for acridine-linked aniline mustards: consequences of varying the reactivity of the mustard.
Gourdie TA; Valu KK; Gravatt GL; Boritzki TJ; Baguley BC; Wakelin LP; Wilson WR; Woodgate PD; Denny WA
J Med Chem; 1990 Apr; 33(4):1177-86. PubMed ID: 2319563
[TBL] [Abstract][Full Text] [Related]
16. Potential anticancer agents. 4. Schiff bases from benzaldehyde nitrogen mustards.
Shekawat DR; Sabnis SS; Deliwala CV
J Med Chem; 1972 Nov; 15(11):1196-7. PubMed ID: 4654676
[No Abstract] [Full Text] [Related]
17. Mutagenicity of cancer chemotherapeutic agents in the Salmonella/microsome test.
Benedict WF; Baker MS; Haroun L; Choi E; Ames BN
Cancer Res; 1977 Jul; 37(7 Pt 1):2209-13. PubMed ID: 193638
[TBL] [Abstract][Full Text] [Related]
18. Mutagenic activity of cyclophosphamide, ifosfamide, and trofosfamide in different genes of escherichia coli and salmonella typhimurium after biotransformation through extracts of rodent liver.
Ellenberger J; Mohn G
Arch Toxicol; 1975; 33(3):225-40. PubMed ID: 1096853
[TBL] [Abstract][Full Text] [Related]
19. Potential bioreductive alkylating agents. 2. Antitumor effect and biochemical studies of naphthoquinone derivatives.
Lin AJ; Pardini RS; Cosby LA; Lillis BJ; Shansky CW; Sartorelli AC
J Med Chem; 1973 Nov; 16(11):1268-71. PubMed ID: 4147836
[No Abstract] [Full Text] [Related]
20. New carcinostatic agent with possible selective activity on tumor cells.
Nabih I; Zayed A
J Pharm Sci; 1974 Nov; 63(11):1806-8. PubMed ID: 4530099
[No Abstract] [Full Text] [Related]
[Next] [New Search]
